Table 1.

HGSOC patient demographics.

Total patients	n = 61
Age
Mean (range)	65 (38–82) years
Body mass index (BMI)
Mean (range)	28 (18–48)
Race
White	87% (n = 53)
African American	13% (n = 8)
Stage
II	2% (n = 1)
III	77% (n = 47)
IV	21% (n = 13)
Overall survival (OS)
Mean (range)	35 (0.2–72) months
Progression-free survival (PFS)
Mean (range)	10 (0–32) months
Treatment strategy
Primary debulking	70% (n = 43)
Neoadjuvant chemotherapy (NACT)	30% (n = 18)
BRCA status
Positive	6% (n = 1)
Negative	50% (n = 9)
Unknown	44% (n = 8)
Platinum sensitivity status
Sensitive	50% (n = 9)
Resistant	39% (n = 7)
Unknown	11% (n = 2)

Note: Patient age, BMI, race, stage, OS, PFS, treatment strategy, BRCA, and platinum sensitivity status were recorded for each of the 61 patients in our analyses.